These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 25605764)

  • 21. Yersinia pestis Δ
    Kolodziejek AM; Bearden SW; Maes S; Montenieri JM; Gage KL; Hovde CJ; Minnich SA
    Appl Environ Microbiol; 2023 Feb; 89(2):e0124422. PubMed ID: 36744930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92.
    Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Parham TE; Baze WB; Suarez G; Peterson JW; Chopra AK
    Microbiology (Reading); 2008 Jul; 154(Pt 7):1939-1948. PubMed ID: 18599822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tn-Seq Analysis Identifies Genes Important for Yersinia pestis Adherence during Primary Pneumonic Plague.
    Eichelberger KR; Sepúlveda VE; Ford J; Selitsky SR; Mieczkowski PA; Parker JS; Goldman WE
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32759339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague.
    Hinnebusch BJ; Jarrett CO; Callison JA; Gardner D; Buchanan SK; Plano GV
    Infect Immun; 2011 Dec; 79(12):4984-9. PubMed ID: 21969002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasiveness of the Yersinia pestis ail protein contributes to host dissemination in pneumonic and oral plague.
    Zhang Y; Ying X; He Y; Jiang L; Zhang S; Bartra SS; Plano GV; Klena JD; Skurnik M; Chen H; Cai H; Chen T
    Microb Pathog; 2020 Apr; 141():103993. PubMed ID: 31988008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant.
    Galindo CL; Moen ST; Kozlova EV; Sha J; Garner HR; Agar SL; Chopra AK
    Comp Funct Genomics; 2009; 2009():914762. PubMed ID: 20145715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.
    Bubeck SS; Dube PH
    Clin Vaccine Immunol; 2007 Sep; 14(9):1235-8. PubMed ID: 17652523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
    Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.
    Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X
    Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
    FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challenge.
    Bozue J; Cote CK; Chance T; Kugelman J; Kern SJ; Kijek TK; Jenkins A; Mou S; Moody K; Fritz D; Robinson CG; Bell T; Worsham P
    PLoS One; 2014; 9(8):e104524. PubMed ID: 25101850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence.
    Felek S; Krukonis ES
    Infect Immun; 2009 Feb; 77(2):825-36. PubMed ID: 19064637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. yadBC of Yersinia pestis, a new virulence determinant for bubonic plague.
    Forman S; Wulff CR; Myers-Morales T; Cowan C; Perry RD; Straley SC
    Infect Immun; 2008 Feb; 76(2):578-87. PubMed ID: 18025093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells.
    Hatkoff M; Runco LM; Pujol C; Jayatilaka I; Furie MB; Bliska JB; Thanassi DG
    Infect Immun; 2012 Oct; 80(10):3490-500. PubMed ID: 22851745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague.
    Tidhar A; Flashner Y; Cohen S; Levi Y; Zauberman A; Gur D; Aftalion M; Elhanany E; Zvi A; Shafferman A; Mamroud E
    PLoS One; 2009 Sep; 4(9):e7023. PubMed ID: 19759820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Global Gene Expression Profiles of Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant at Flea and Human Body Temperatures.
    Galindo CL; Sha J; Moen ST; Agar SL; Kirtley ML; Foltz SM; McIver LJ; Kozlova EV; Garner HR; Chopra AK
    Comp Funct Genomics; 2010; 2010():342168. PubMed ID: 20508723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.
    Okan NA; Mena P; Benach JL; Bliska JB; Karzai AW
    Infect Immun; 2010 Mar; 78(3):1284-93. PubMed ID: 20065026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague.
    Fitts EC; Andersson JA; Kirtley ML; Sha J; Erova TE; Chauhan S; Motin VL; Chopra AK
    mSphere; 2016; 1(6):. PubMed ID: 27981238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in Strain Pathogenicity of Septicemic Yersinia pestis Infection in a TLR2
    O'Donnell KL; Knopick PL; Larsen R; Sarkar S; Nilles ML; Bradley DS
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31907194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.